Understanding Protein Behavior for Drug Design
Markov State Model approaches for folding, binding and design
['FUNDING_R01'] · TEMPLE UNIV OF THE COMMONWEALTH · NIH-11146375
This project is creating advanced computer models to better understand how proteins in our bodies work and how medicines can attach to them, which helps in designing new drugs for conditions like cancer and COVID-19.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | TEMPLE UNIV OF THE COMMONWEALTH (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-11146375 on ClinicalTrials.gov |
What this research studies
Our bodies rely on proteins that constantly change shape and interact with other molecules, including medicines. This project develops sophisticated computer simulations, called Markov state models, to predict these complex movements and interactions. By understanding how proteins fold and how drugs bind to them, we can design more effective treatments. This work builds on efforts that helped screen potential COVID-19 drugs and aims to improve how we discover new medicines for various diseases, including cancers.
Who could benefit from this research
Good fit: This foundational computational work does not directly involve patients, but future patients with conditions like cancer or viral infections could benefit from the improved drug discovery methods.
Not a fit: Patients seeking immediate treatment or direct clinical participation will not find a benefit from this early-stage computational methodology development.
Why it matters
Potential benefit: If successful, this work could significantly speed up and improve the process of discovering and designing new medications for diseases like cancer and viral infections.
How similar studies have performed: This project builds upon existing molecular simulation techniques and prior work in virtual drug screening, while developing novel combinations and improvements to these methods.
Where this research is happening
PHILADELPHIA, UNITED STATES
- TEMPLE UNIV OF THE COMMONWEALTH — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VOELZ, VINCENT — TEMPLE UNIV OF THE COMMONWEALTH
- Study coordinator: VOELZ, VINCENT
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers